However, theyre not completely risk-free
Most notably, the top causes of human death, heart disease, diabetes, kidney disease, liver inflammation (fatty liver) but also improving joint issues that can be caused by excess weight, aging and inactivity including back, hip and knee pain and surgeries
The potential of the emerging Glucagon-like Peptide-1 (GLP-1) Agonists in changing the current clinical practice guidelines is crucial to analyze, especially when it comes to real-world scenarios
Her work has appeared in EatingWell, Food & Wine, The Spruce Eats, and Real Simple
When the optic nerve does not receive enough blood flow, sudden vision loss can occur
Documented comorbidities like hypertension, type 2 diabetes, or sleep apnea significantly improve approval odds